Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

PNAS 100 (8): 4772-4777

Copyright © 2003 by the National Academy of Sciences.


The cyclopentenone 15-deoxy-{Delta}12,14-prostaglandin J2 binds to and activates H-Ras

José Luis Oliva*,{dagger}, Dolores Pérez-Sala{dagger},{ddagger},§, Antonio Castrillo{dagger}, Natalia Martínez*, F. Javier Cañada{ddagger}, Lisardo Boscá, and José M. Rojas*,§

*Unidad de Biología Celular, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain; {ddagger}Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, 28006 Madrid, Spain; and Instituto de Bioquímica and Centro Nacional de Investigaciones Cardiovasculares, Centro Mixto Consejo Superior de Investigaciones Científicas–Universidad Complutense de Madrid, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain

Received for publication September 26, 2002.

Abstract: The cyclopentenone 15-deoxy-{Delta}12,14-prostaglandin J2 (15d-PGJ2) induces cell proliferation and mitogen-activated protein kinase activation. Here, we describe that these effects are mediated by 15d-PGJ2-elicited H-Ras activation. We demonstrate that this pathway is specific for H-Ras through the formation of a covalent adduct of 15d-PGJ2 with Cys-184 of H-Ras, but not with N-Ras or K-Ras. Mutation of C184 inhibited H-Ras modification and activation by 15d-PGJ2, whereas serum-elicited stimulation was not affected. These results describe a mechanism for the activation of the Ras signaling pathway, which results from the chemical modification of H-Ras by formation of a covalent adduct with cyclopentenone prostaglandins.

Key Words: mitogen-activated protein kinase||cell proliferation||posttranslational modification

{dagger} J.L.O., D.P.-S., and A.C. contributed equally to this work.

§ To whom correspondence should be addressed. E-mail: dperezsala{at} or jmrojas{at}

Edited by Edward M. Scolnick, Merck & Co., Inc., West Point, PA, and approved February 7, 2003

This paper was submitted directly (Track II) to the PNAS office.

Regulation of redox signalling by an electrophilic cyclic nucleotide.
T. Akaike, M. Nishida, and S. Fujii (2013)
J. Biochem. 153, 131-138
   Abstract »    Full Text »    PDF »
Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function.
J. R. Springstead, B. G. Gugiu, S. Lee, S. Cha, A. D. Watson, and J. A. Berliner (2012)
J. Lipid Res. 53, 1304-1315
   Abstract »    Full Text »    PDF »
Oxidation of HRas cysteine thiols by metabolic stress prevents palmitoylation in vivo and contributes to endothelial cell apoptosis.
J. R. Burgoyne, D. J. Haeussler, V. Kumar, Y. Ji, D. R. Pimental, R. S. Zee, C. E. Costello, C. Lin, M. E. McComb, R. A. Cohen, et al. (2012)
FASEB J 26, 832-841
   Abstract »    Full Text »    PDF »
Functional Specificity of Ras Isoforms: So Similar but So Different.
E. Castellano and E. Santos (2011)
Genes & Cancer 2, 216-231
   Abstract »    Full Text »    PDF »
Mammalian Son of Sevenless Guanine Nucleotide Exchange Factors: Old Concepts and New Perspectives.
J. M. Rojas, J. L. Oliva, and E. Santos (2011)
Genes & Cancer 2, 298-305
   Abstract »    Full Text »    PDF »
The Anti-inflammatory Prostaglandin 15-Deoxy-{Delta}12,14-PGJ2 Inhibits CRM1-dependent Nuclear Protein Export.
M. Hilliard, C. Frohnert, C. Spillner, S. Marcone, A. Nath, T. Lampe, D. J. Fitzgerald, and R. H. Kehlenbach (2010)
J. Biol. Chem. 285, 22202-22210
   Abstract »    Full Text »    PDF »
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.
L. M. I. Koharudin, H. Liu, R. Di Maio, R. B. Kodali, S. H. Graham, and A. M. Gronenborn (2010)
PNAS 107, 6835-6840
   Abstract »    Full Text »    PDF »
15-Deoxy-{Delta}12,14-Prostaglandin J2 Biphasically Regulates the Proliferation of Mouse Hippocampal Neural Progenitor Cells by Modulating the Redox State.
T. Katura, T. Moriya, and N. Nakahata (2010)
Mol. Pharmacol. 77, 601-611
   Abstract »    Full Text »    PDF »
15-Deoxy-{Delta}12,14-prostaglandin J2 Impairs Phosphatidylcholine Synthesis and Induces Nuclear Accumulation of Thiol-modified Cytidylyltransferase.
A. J. Ryan, B. B. Chen, P. R. Vennalaganti, F. C. Henderson, L. A. Tephly, A. B. Carter, and R. K. Mallampalli (2008)
J. Biol. Chem. 283, 24628-24640
   Abstract »    Full Text »    PDF »
Regulation of TLR2 Expression by Prostaglandins in Brain Glia.
H. J. Yoon, S.-B. Jeon, I.-H. Kim, and E. J. Park (2008)
J. Immunol. 180, 8400-8409
   Abstract »    Full Text »    PDF »
15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-{alpha} via Covalent Modification of DNA-Binding Domain.
H.-J. Kim, J.-Y. Kim, Z. Meng, L. H. Wang, F. Liu, T. P. Conrads, T. R. Burke, T. D. Veenstra, and W. L. Farrar (2007)
Cancer Res. 67, 2595-2602
   Abstract »    Full Text »    PDF »
PPAR{gamma}1 attenuates cytosol to membrane translocation of PKC{alpha} to desensitize monocytes/macrophages.
A. von Knethen, M. Soller, N. Tzieply, A. Weigert, A. M. Johann, C. Jennewein, R. Kohl, and B. Brune (2007)
J. Cell Biol. 176, 681-694
   Abstract »    Full Text »    PDF »
Protection of RPE Cells from Oxidative Injury by 15-Deoxy-{Delta}12,14-Prostaglandin J2 by Augmenting GSH and Activating MAPK.
S. Qin, A. P. McLaughlin, and G. W. De Vries (2006)
Invest. Ophthalmol. Vis. Sci. 47, 5098-5105
   Abstract »    Full Text »    PDF »
Nrf2-mediated Induction of Cytoprotective Enzymes by 15-Deoxy-{Delta}12,14-Prostaglandin J2 Is Attenuated by Alkenal/one Oxidoreductase.
X. Yu, P. A. Egner, J. Wakabayashi, N. Wakabayashi, M. Yamamoto, and T. W. Kensler (2006)
J. Biol. Chem. 281, 26245-26252
   Abstract »    Full Text »    PDF »
Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases.
A. Alfranca, M. A. Iniguez, M. Fresno, and J. M. Redondo (2006)
Cardiovasc Res 70, 446-456
   Abstract »    Full Text »    PDF »
Potentiation of tumor formation by topical administration of 15-deoxy-{Delta}12,14-prostaglandin J2 in a model of skin carcinogenesis.
O. Millan, D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Perez-Sala, J. M. Rojas, A. Cano, and L. Bosca (2006)
Carcinogenesis 27, 328-336
   Abstract »    Full Text »    PDF »
Identification of Novel Protein Targets for Modification by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Mesangial Cells Reveals Multiple Interactions with the Cytoskeleton.
K. Stamatakis, F. J. Sanchez-Gomez, and D. Perez-Sala (2006)
J. Am. Soc. Nephrol. 17, 89-98
   Abstract »    Full Text »    PDF »
{alpha},{beta}-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor {gamma}.
T. Shiraki, N. Kamiya, S. Shiki, T. S. Kodama, A. Kakizuka, and H. Jingami (2005)
J. Biol. Chem. 280, 14145-14153
   Abstract »    Full Text »    PDF »
The mitochondrial respiratory complex I is a target for 15-deoxy-{Delta}12,14-prostaglandin J2 action.
B. Martinez, A. Perez-Castillo, and A. Santos (2005)
J. Lipid Res. 46, 736-743
   Abstract »    Full Text »    PDF »
Protein Thiol Modification by 15-deoxy-{Delta}12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes.
F. J. Sanchez-Gomez, E. Cernuda-Morollon, K. Stamatakis, and D. Perez-Sala (2004)
Mol. Pharmacol. 66, 1349-1358
   Abstract »    Full Text »    PDF »
The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras.
J. L. Oliva, N. Zarich, N. Martinez, R. Jorge, A. Castrillo, M. Azanedo, S. Garcia-Vargas, S. Gutierrez-Eisman, A. Juarranz, L. Bosca, et al. (2004)
J. Biol. Chem. 279, 33480-33491
   Abstract »    Full Text »    PDF »
Inhibition of Activator Protein 1 Activation, Vascular Endothelial Growth Factor, and Cyclooxygenase-2 Expression by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Colon Carcinoma Cells: Evidence for a Redox-Sensitive Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism.
R. Grau, M. A. Iniguez, and M. Fresno (2004)
Cancer Res. 64, 5162-5171
   Abstract »    Full Text »    PDF »
Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-{Delta}12,14-prostaglandin J2.
D. Perez-Sala, E. Cernuda-Morollon, and F. J. Canada (2003)
J. Biol. Chem. 278, 51251-51260
   Abstract »    Full Text »    PDF »
Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins.
T. Shibata, T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, J. Yodoi, and K. Uchida (2003)
J. Biol. Chem. 278, 26046-26054
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882